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Abstract 
Background: Epidemics of meningococcal meningitis cause significant health problems especially in Sub‑Saharan 
Africa. Novel anti‑infective candidates are needed. In modern anti‑adhesion therapy initial attachment of bacteria to 
host cells is prevented. Our unique studies have revealed anti‑adhesive candidates from natural products, namely 
milk and berries, against Neisseria meningitidis adhesion. In the present study against N. meningitidis adhesion, a novel 
binding inhibitor was found; salvianolic acid B (SA‑B), a polyphenol from the radix Salviae miltiorrhizae, an important 
part of Chinese folk medicine.
Methods: In order to test inhibition of meningococcal pili binding and anti‑adhesion activity of SA‑B, bovine thy‑
roglobulin, a reference glycoprotein for meningococcal receptor was used in a microtiter plate assay. Inhibitory activ‑
ity was tested by using serial dilutions of SA‑B extracts of 98 and 70 % purity. Results were confirmed in a HEC‑1B cell 
dot assay and antimicrobial activity was measured by using a microbroth dilution assay.
Results: Almost total (93 %) inhibition of pili binding, anti‑adhesion, was achieved with the 70 % extract of SA‑B at 
the concentration of 0.3 mg/mL in the bovine thyroglobulin reference model. 50 % binding inhibition activity was 
achieved with 0.6 µg/mL of the SA‑B extract. Total inhibition of the pili binding to HEC‑1B cells was found at the 
tested concentration of 0.5 mg/mL. The 98 % pure SA‑B resulted in weaker inhibition. At the concentration of 0.3 mg/
mL 78 % inhibition was achieved in the thyroglobulin model. For 50 % inhibition 2.4 μg/mL of pure SA‑B was needed. 
The difference between the binding inhibition activities (70 and 98 % pure SA‑B) was statistically significant (P = 0.03). 
Antimicrobial activity of 70 % SA‑B, when investigated against N. meningitidis, was detected only in relatively high 
concentrations.
Conclusions: Our results indicate that plant SA‑B may prevent meningococcal infections by inhibiting meningococ‑
cal binding and may thus have an impact on the amount of nasopharyngeal carriers of N. meningitidis. This may pre‑
vent the spreading of meningococcal infections between humans. One could conclude that SA‑B and its source dried 
radix S. miltiorrhizae, which is an important part of Chinese folk medicine, could be valuable candidates for further 
research in meningococcal disease prevention.
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Background
Due to increasing bacterial resistance it is important to 
search for new means against bacterial infections [1]. In 
anti-adhesion therapy the adhesion of bacteria to host 
tissues is inhibited by soluble carbohydrates or their 
analogs [1–3]. Based on animal experiments soluble car-
bohydrates can protect against experimental infections 
[4]. Studies with natural products: milk, berries, berry 
polyphenols and herbal medicines have indicated these 
products being possible sources for anti-adhesive agents 
[5–14].
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Neisseria meningitidis, which is an important human 
pathogen, colonizing the nasopharynx of 10–35  % of 
young adults, can be transmitted from person to person 
by droplet infection [15]. For a small amount of the colo-
nised people meningococci can cause life-threatening 
infections, such as meningococcal septicaemia or men-
ingitis [16]. Epidemics of meningitis are a significant 
health problem especially in Sub-Saharan Africa [17] but 
also amongst risk groups such as in military forces. The 
attachment of N. meningitidis to human mucosal epithe-
lial cells, the crucial step of the infection [18], is mediated 
by type IV pili [19]. HEC-1B epithelial cell line [9, 19] and 
bovine thyroglobulin [5] have been previously used for 
adhesion and binding, as well as functioned as binding 
inhibition models for meningococcal pili.
Our previous studies have shown that in the thyroglob-
ulin model oligosaccharides isolated from human and 
bovine milk have anti-adhesion activity against N. men-
ingitidis [5]. We have also shown that in microtiter well 
binding and cell culture inhibition assays polyphenolic 
fractions extracted from berries possess anti-adhesive 
activity against N. meningitidis [6, 9].
In the present study we tested anti-adhesion and anti-
microbial activities of salvianolic acid B (SA-B) (Fig.  1), 
a water soluble polyphenolic acid extracted from dried 
radix Salvia miltiorrhiza Bunge, which is an important 
part of Chinese folk medicine. Over 20 Salvia species 
have been used in traditional Chinese folk medicine for 
the treatment of coronary heart diseases and strokes. 
According to Li et  al. [20] only the official species of S. 
miltiorrhiza Bunge meet the requirements set forth 
and ascribed as the formal traditional medicinal plant 
Danshen.
SA-B has therapeutic potential against different medi-
cal conditions [21–23]. SA-B has been used in a clinical 
trial and has not displayed any obvious side effects [24]. 
To our knowledge this is the first report on anti-infective 
activity of SA-B and the first report on anti-adhesion 
activity of Chinese herbs against N. meningitis.
Methods
Materials
Biomax Ultrafree-15 centrifugal filter devises with 
100  kDa cut offs were obtained from Millipore. 
d-biotinoyl-ε-aminocaproic acid-N-hydroxysuccinimide 
ester, streptavidin-POD conjugate, and ABTS-substrate 
were purchased from Roche diagnostics. Bovine thy-
roglobulin was obtained from Sigma. Polyvinylchloride 
microtiter plates (Falcon Flexible Plate) were from Bec-
ton–Dickinson Labware. Bacterial culture plates were 
purchased from Sarstedt and GCB agar from Oxoid Ltd. 
High-glucose DMEM cell culture medium, fetal bovine 
serum (FBS), l-glutamine, trypsin–EDTA solution and 
sterile phosphate buffered saline (PBS) for cell culture 
were from Gibco and cell culture plates from Greiner. 
Nitrocellulose membranes (Protran®) were obtained 
from Schleicher & Schuell BioScience. Super Signal solu-
tion was from Pierce and X-ray Hyperfilm™ from Amer-
sham Pharmacia Biotech.
Salvianolic acid B samples
Purified radix extract SA-B (98 % purity) was purchased 
from Ivy Fine Chemicals. SA-B extract of 70 % purity was 
purified from the radix S. miltiorrhizae by using ethanol 
extraction followed by column chromatography accord-
ing to the method of Fung et al., 1993 [25]. Shortly: 500 g 
of S. miltiorrhiza Bunge was heated with 50  % ethanol 
(3 L) for 4 h. The mixture was allowed to cool down, after 
which it was filtered. After evaporation of ethanol the 
resulting aqueous solution was concentrated and allowed 
to stand overnight. After filtration, the aqueous solution 
was freeze-dried to a powder-like product (35  g). Col-
umn chromatography was then carried out by using C18 
reverse phase column (Alltech, USA) with solvent gradi-
ent water to 80 % aqueous methanol. The separation was 
monitored by thin layer chromatography on silica gel 
(Merck, Germany) with solvent system n-butanol/acetic 
acid/H20 and the purity was determined by using HPLC 
chromatography on C18 reverse phase column (Ultra-
sphere-ODS from Beckman, USA with 20  % aqueous 
CH3CN, UV 254 detector).
Initially both SA-B samples were tested for the binding 
inhibition activity against N. meningitidis. All the other 
experiments were carried out by using the SA-B of 70 % 
purity.
Bacterial strain and culture conditions
Neisseria meningitidis serogroup C class I strain 8013 
(X. Nassif, INSERM U570, Paris, France) was cultured at Fig. 1 Molecular structure of SA‑B
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37 °C in CO2 atmosphere for 18 h on GCB agar contain-
ing supplements described by Kellogg et al. [26].
Isolation and biotin labelling of meningococcal pili
Isolation and biotin labelling of pili were carried out as 
described before [5, 6]. N. meningitidis bacteria were har-
vested from five plates and suspended into 20 mL of ice 
cold and sterile Hepes buffer (10 mmol/L). The suspension 
was mixed vigorously for 30 s and centrifuged (20 min at 
4  °C, 8000g). The supernatant was applied to a Biomax 
Ultrafree-15 centrifugal filter device (cut off 100 kDa) and 
centrifuged (at 4 °C, 1000g). The concentrate was washed 
twice with 15 mL of Hepes buffer (10 mmol/L) and cen-
trifuged as described above, to the volume of 1 mL. The 
concentrate was collected and stored at 4 °C. Biotin label-
ling of the isolated pili was performed in PBS by using 
d-biotinoyl-ε-aminocaproic acid-N-hydroxysuccinimide 
ester according to the instructions of the manufacturer. 
The biotin-labelled pili were stored at 4 °C.
Inhibition of pili binding to bovine thyroglobulin
The inhibition of meningococcal pili binding to bovine thy-
roglobulin was tested as described before by using dry milk 
powder as a background control [6]. Aliquots of 100 µL of 
thyroglobulin (0.1  mg/mL) were incubated on polyvinyl-
chloride microtiter plates at 4 °C overnight. The wells were 
washed five times with washing buffer [0.05 % (v/v) Tween 
20 in PBS, pH 7.4]. The non-specific binding sites were 
blocked by dry milk powder solution [5 % (w/v) dry milk 
powder, 0.05  % (v/v) Tween 20 in PBS, pH 7.4], 250  µL/
well. The plates were incubated for 1 h at room tempera-
ture. Biotin labelled pili were diluted 1:4 in PBS. Both of the 
SA-B samples were diluted with water to the concentration 
of 0.625 mg/mL, serially diluted down to the concentration 
of 0.00125 mg/mL and dilutions were separately mixed 1:1 
with biotin-labelled pili. Pili-sample mixtures were incu-
bated at room temperature for 1 h on a gentle rocking plat-
form. Biotin labelled pili diluted 1:8 in PBS without herbal 
extract addition was treated identically to samples and used 
as a control. Then, 100  µL of the pre incubated solutions 
were added to washed, thyroglobulin-coated microtiter 
plate wells. After 1 h incubation at room temperature the 
wells were washed five times as described above, followed 
by Streptavidin-POD addition [100  µL of Streptavidin-
POD conjugate in dry milk powder solution (1:4000)] and 
by 1 h incubation at room temperature. After five washes 
with washing buffer, an aliquot of 100  µL of ABTS-sub-
strate was added. The absorbance was measured at 405 nm. 
The assays were always carried out in triplicates.
Dot binding inhibition assay
Human epithelial HEC-1B cell line, a cell culture model 
for N. meningitidis [9, 19] was obtained from Xavier 
Nassif (INSERM U570, Paris, France). Cells were cul-
tured on cell culture dishes in high-glucose DMEM sup-
plemented with 10  % heat-inactivated FBS and 4  mM 
l-glutamine at 37 °C with 5 % CO2, without an addition 
of antibiotics. Cells from passages between 11 and 14 
were harvested using a diluted trypsin–EDTA solution 
and centrifuged at 400g, 4 min. Cells were washed twice 
with ice cold sterile PBS, centrifuged as described above 
and stored at −20 °C until used.
In dot binding inhibition assay the anti-adhesion activity 
of SA-B was tested against meningococcal pili binding to 
HEC-1B cells. HEC-1B cells were collected from one plate 
as described above. They were suspended in 200 µL of PBS 
and diluted 1:10 with PBS. Cell suspensions of 2 µL were 
pipetted as dots on a nitrocellulose membrane and allowed 
to dry. Dry milk powder solution [5 % (w/v) dry milk pow-
der, 0.05  % (v/v) Tween 20 in PBS, pH 7.4] was used to 
block the non-specific binding sites. After two hours of 
incubation (at room temperature) with gentle rocking on 
the rocking platform, the membrane was washed three 
times with washing buffer [0.05 % (v/v) Tween 20 in PBS, 
pH 7.4]. The 70 % SA-B sample was diluted with water to 
the concentration of 1  mg/mL. The diluted sample and 
biotin labelled diluted pili (1:10 in dry milk powder solu-
tion) were mixed 1:1 and preincubated for 1  h at room 
temperature. Labelled pili—sample mixture was added 
into the washed membrane and the incubation was per-
formed for 90  min at room temperature. Biotin labelled 
pili dilution without herbal extract addition was treated 
identically to the sample and used as a positive control. 
After three washes with washing buffer, Streptavidin-POD 
conjugate diluted in dry milk powder solution (1:4000) was 
added into the membrane. The membrane was incubated 
for 1  h at room temperature. Finally, the membrane was 
washed and Super Signal Solution was added. The mem-
brane was exposed to Hyperfilm™ and developed.
Antimicrobial assay on microtiter plates
Antimicrobial activity of SA-B was tested against N. 
meningitidis. Overnight plate-cultured N. meningitidis 
bacteria were suspended in cold GC broth to an optical 
density of 0.180 at 550  nm. The corresponding colony 
forming unit (CFU) was 108. Diluted bacterial suspension 
(90  µL) and SA-B dilutions ranging from 2 to 0.03  mg/
mL (10 µL) were incubated on microtiter plate at 37 °C, 
in CO2 atmosphere, for 2 h. As a control, bacteria were 
incubated in the absence of SA-B or with ampicillin 
(0.1 mg/mL). The antimicrobial activity was analysed by 
plating the incubation mixtures in triplicate on GCB-agar 
plates. The survived colony forming units were counted 
next day. The growth inhibition was analysed by compar-
ing the CFUs of bacteria–sample -mixture and control 
bacteria.
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Statistical analysis
Results for the inhibition assay were reported as 
mean  ±  standard deviation (SD). Two-tailed, unpaired 
Student’s t test (Microsoft Excel 2007, Microsoft Corp., 
Santa Rosa, CA, USA) was used for calculating the sig-
nificance of the binding inhibition for both SA-B of 70 % 
purity and SA-B of 98 % purity compared to control, and 
for calculating the differences between inhibition caused 
by SA-B of 70 % purity and by SA-B of 98 % purity. The 
significance was defined as values of P < 0.05. Results for 
the antimicrobial assay were reported as mean ± stand-
ard deviation (SD). Two-tailed, unpaired Student’s t test 
(Microsoft Excel 2007, Microsoft Corp., Santa Rosa, CA, 
USA) was used for calculating the significance of the dif-
ferences between CFUs from antimicrobial tests and 
control bacteria. Significance was defined as a value of 
P < 0.001.
Results
Anti‑adhesive activity of the SA‑B extracts
To demonstrate the SA-B anti-adhesive activity, both 
SA-B of 98  % purity and SA-B of 70  % purity were 
tested. The binding inhibition for both SA-B of 70  % 
purity (P  <  0.001) and SA-B of 98  % purity (P  <  0.001) 
was significant compared to control. Binding inhibition 
activity of the SA-B with 98  % purity was 78  % at the 
concentration of 0.3  mg/mL, and concentration for the 
50 % inhibition was 2.4 µg/mL. The SA-B extract of 70 % 
purity inhibited the pili binding almost totally (93  %) 
at the concentration of 0.3 mg/mL and 50 % inhibitory 
activity was achieved at the concentration of 0.6 µg/mL. 
Quite similar results in the binding inhibition activity 
were achieved with both extracts, however the SA-B of 
70 % purity was significantly (P = 0.03) more efficient in 
binding inhibition than SA-B of 98 % purity (Fig. 2). In 
the lowest concentrations (below 0.01  mg/mL) the dif-
ference was non-existent, except at the concentration of 
0.002 mg/mL (P = 0.01). When the 70 % SA-B (0.5 mg/
mL) extract was tested for the inhibition of meningococ-
cal pili binding to HEC-1B epithelial cells, the extract 
was able to completely inhibit the attachment of menin-
gococcal pili (Fig. 3).
Antimicrobial activity of the SA‑B
Antimicrobial activity has been found amongst berries, 
herbs and berry phenolics [27–29]. In antimicrobial 
assay the growth of N. meningitidis was inhibited effec-
tively (P < 0.001) in relatively high concentrations (2 mg/
Fig. 2 Inhibition of meningococcal pili binding to bovine thyroglobulin by salvianolic acid B (98 and 70 % purity). Tested concentrations ranged 
from 0.313 mg/mL to 0.6 µg/mL for both SA‑Bs. Each point on the curves represents the mean ± SD, n = 9. The binding of pili to reference glyco‑
protein was significantly inhibited by both SA‑B of 70 % purity (P < 0.001) and SA‑B of 98 % purity (P < 0.001) when compared to control (no inhibi‑
tor). The difference between the inhibition activity caused by SA‑B of 70 % purity compared to SA‑B of 98 % purity was significant (*P = 0.03, except 
for the concentration of 0.002 mg/mL *P = 0.01)
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mL) of the 70 % SA-B. Other tested SA-B concentrations 
(1–0.03 mg/mL) did not have significant effect on menin-
gococcal growth and the bacterial survival was found to 
be between 58 and 89 %, respectively. Bacterial survival 
with ampicillin was 23 % (Fig. 4).
Discussion
Even if the herbal solution is efficacious, immediate 
determination of the active substances may not be pos-
sible, particularly in herbal solutions that contains many 
compounds. Components in a crude extract could act 
synergistically, have unknown interactions and interact 
to diminish possible adverse effects of the components. 
Also, if used properly, a mixture of several crude extracts 
could have greater beneficial effects compared to a sin-
gle plant extract. This has been shown by using Chinese 
herbs against hemagglutination and adhesion of Escher-
chia coli [30].
Neisseria meningitidis adhesion is mediating by type 4 
pili, which carries two main potential adhesins [31, 32], 
but the adhesion mechanisms are complicated [33]. The 
SA-B sample of 70  % purity may contain components 
that interact with different binding activities of N. men-
ingitidis. This may be one explanation for higher binding 
inhibitory activity of 70 % SA-B compared to 98 % SA-B. 
Our previous results suggest carbohydrate recognition 
for N. meningitidis and binding inhibition by milk oligo-
saccharides [5]. Parallel to results achieved here we have 
also shown that berry extracts rich in polyphenols are 
active against pili binding [6, 9].
Bacterial binding to host tissues is an important phase 
before bacterial infections [1, 2]. In this study we found 
binding inhibition activity of SA-B against meningococ-
cal pili, which mediate N. meningitidis adhesion. There is 
a lack of proper vaccination against N. meningitidis [17]. 
Natural products as anti-adhesives could offer an impor-
tant solution for prevention. As an anti-adhesive agent 
SA-B could possibly reduce the number of nasopharyn-
geal carries and thus reduce the risk of spreading the 
infection. The use of known, natural nutritional products 
in a form of an extract rather than a purified compound 
would be practical and economic for prevention pur-
poses. This could be useful especially in developing coun-
tries, where proper preservation of vaccines is limited 
and epidemics of meningitis are a major health problem.
Here we show the inti-infective, anti-adhesive effect of 
SA-B. In anti-adhesion therapy the interaction between 
the pathogen and the host is inhibited without killing 
the bacteria thus avoiding rise of bacterial resistance 
[34]. Antimicrobial activity of the SA-B was only found 
in higher and not in lower concentrations, and in con-
centrations possessing binding inhibitory activity. The 
inhibitory activity found in the present study was not 
antimicrobial but anti-adhesive indicating SA-B as a can-
didate for anti-adhesion therapy against N. meningitidis.
Conclusions
Our results indicate that both 70 and 98  % pure SA-B 
extracts may prevent meningococcal infections by inhib-
iting meningococcal binding to host cells. It can be 
assumed that this inhibition may also have a reducing 
impact on the amount of nasopharyngeal carriers of N. 
meningitidis and thus preventing the spread of meningo-
coccal infections between humans. One could conclude 
that SA-B and its source, dried radix Salviae miltiorrhi-
zae, an important part of Chinese folk medicine, could be 
valuable candidates for further research in meningococ-
cal disease prevention.
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Fig. 3 Inhibition of meningococcal pili binding to HEC‑1B human 
epithelial cells by SA‑B. Positive control shows pili biding without 
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Fig. 4 Antimicrobial activity of SA‑B against Neisseria meningitidis. 
Bacterial survival compared with control, mean ± SD of three experi‑
ments. *P < 0.001 against the bacterial control
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